Internal Medicine, Gastroenterology · Newton, MA
NPI
1922083542
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2000 Washington St, Suite 368
Newton, MA, 02462
Phone (617) 969-1227
Groups this clinician bills Medicare through
Medicare paid, 2024
$212K
6,911 services
Medicare patients, 2024
610
Average age 74
Drug cost, 2024
$297K
764 prescriptions
Company payments, 2024
$152
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elissa E Kaplan was code 99215 (office e&m - established), 153 times for 136 patients. In total Elissa E Kaplan billed 6,911 services in 41 codes, and Medicare paid $212K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 153 | 136 | $140.24 | $21K |
| 45380 Lower GI Endoscopy - Other | Facility | 146 | 146 | $108.42 | $16K |
| 45385 Colonoscopy - Lesion Removal | Facility | 126 | 126 | $215.97 | $27K |
| 43239 Upper GI Endoscopy | Facility | 74 | 73 | $82.15 | $6,079 |
| 99204 Office E&M - New | Office | 65 | 65 | $127.08 | $8,260 |
| 45378 Lower GI Endoscopy - Other | Facility | 48 | 48 | $155.94 | $7,485 |
| 99222 Hospital E&M - Initial | Facility | 38 | 37 | $108.64 | $4,128 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 33 | 33 | $3.85 | $127 |
| 43235 Upper GI Endoscopy | Facility | 24 | 24 | $81.98 | $1,967 |
| 45380 Lower GI Endoscopy - Other | Office | 24 | 24 | $241.35 | $5,792 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 19 | 19 | $191.85 | $3,645 |
| 45385 Colonoscopy - Lesion Removal | Office | 17 | 17 | $317.08 | $5,390 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 13 | 13 | $183.28 | $2,383 |
By year: 2022 $137K for 2,964 services; 2023 $121K for 2,464 services; 2024 $212K for 6,911 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elissa E Kaplan prescribed most often to Medicare patients was Famotidine, with 166 prescriptions and refills. In total Elissa E Kaplan wrote 764 Medicare prescriptions that cost $297K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 166 | 470 | 57 | $2,228 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 113 | 113 | 112 | $7,070 |
| Omeprazole Generic | 60 | 142 | 28 | $702 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 55 | 55 | 55 | $847 |
| Linzess Linaclotide | 50 | 88 | 14 | $46K |
| Mesalamine Generic | 46 | 97 | 13 | $25K |
| Colestipol Hcl Generic | 32 | 76 | Under 11 | $3,011 |
| Sucralfate Generic | 23 | 58 | Under 11 | $894 |
| Pantoprazole Sodium Generic | 19 | 57 | Under 11 | $205 |
| Mesalamine Er Mesalamine | 18 | 54 | Under 11 | $9,875 |
| Sulfasalazine Generic | 17 | 33 | Under 11 | $864 |
| Dicyclomine Hcl Generic | 16 | 38 | Under 11 | $584 |
| Lactulose Generic | 13 | 23 | Under 11 | $254 |
| Apriso Mesalamine | 12 | 20 | Under 11 | $10K |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 11 | 11 | 11 | $1,893 |
Brand drugs: 161 claims; generic drugs: 603 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Elissa E Kaplan $152 ($152 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $152.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $152 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.